![Hideyuki Takahashi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Hideyuki Takahashi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PuREC KK
![]() PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Directeur/Bestuurslid | - | - |
President | - | - |
Loopbaan van Hideyuki Takahashi
Statistieken
Internationaal
Japan | 2 |
Operationeel
Director/Board Member | 1 |
President | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
PuREC KK
![]() PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Health Technology |
- Beurs
- Insiders
- Hideyuki Takahashi
- Ervaring